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Abstract
The current study tests the hypothesis that peroxisome proliferator-activated receptor b (PPARb) has a role in liver
regeneration due to its effect in regulating energy homeostasis and cell proliferation. The role of PPARb in liver regeneration
was studied using two-third partial hepatectomy (PH) in Wild-type (WT) and PPARb-null (KO) mice. In KO mice, liver
regeneration was delayed and the number of Ki-67 positive cells reached the peak at 60 hr rather than at 36–48 hr after PH
shown in WT mice. RNA-sequencing uncovered 1344 transcriptomes that were differentially expressed in regenerating WT
and KO livers. About 70% of those differentially expressed genes involved in glycolysis and fatty acid synthesis pathways
failed to induce during liver regeneration due to PPARb deficiency. The delayed liver regeneration in KO mice was
accompanied by lack of activation of phosphoinositide-dependent kinase 1 (PDK1)/Akt. In addition, cell proliferation-
associated increase of genes encoding E2f transcription factor (E2f) 1–2 and E2f7–8 as well as their downstream target
genes were not noted in KO livers 36–48 hr after PH. E2fs have dual roles in regulating metabolism and proliferation.
Moreover, transient steatosis was only found in WT, but not in KO mice 36 hr after PH. These data suggested that PPARb-
regulated PDK1/Akt and E2f signaling that controls metabolism and proliferation is involved in the normal progression of
liver regeneration.
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Introduction
Proliferating cells require metabolic activity to generate energy
and intermediates for the biosynthesis of macromolecules used for
producing cell or tissue mass [1]. Increased aerobic glycolysis and
fatty acid (FA) synthesis are both considered as major metabolic
alterations during cell proliferation. Cell proliferation is controlled
by the cell cycle, which is regulated by Cyclins, Cyclin-dependent
kinases (Cdks), or E2fs [2].
Peroxisome proliferator-activated receptors are nuclear receptor
ligand-depended transcription factors that regulate gene expres-
sion. Three types of PPARs (a, b/d and c) were identified. Even
though they share sequence similarity, they all have unique
physiological functions involved in control of metabolism [3].
PPARa regulates FA transport and metabolism and regulates
energy homeostasis while PPARc is involved in adipocyte
differentiation and lipid storage in adipose tissue [4]. PPARb
participates in the regulation of lipid and glucose metabolism,
wound healing and inflammation [5].
The roles of PPARa and PPARc in liver regeneration were
studied and different results were obtained [6–10]. Some studies
showed that PPARa deficiency delayed liver regeneration after
partial hepatectomy (PH) in mice through inhibition of genes
involved in cell cycle control, cytokine signaling, fat metabolism,
and impaired Ras signaling [6,8]. Metabolomic studies also
revealed activation of PPAR signaling and increased lipid
metabolism in regenerating rat livers after PH [11]. Pharmaco-
logical activation of PPARa in rodent causes hepatomegaly and
leads to the development of liver cancer indicating its role in
proliferation [12]. However, other studies concluded that PPARa
is not essential for the increased expression of Cdks and Cyclins as
well as cell proliferation after PH [7]. Similarly, contradicting data
have been reported for PPARc, activation of PPARc by
pioglitazone inhibits PH-induced hepatocyte proliferation in rat
[13], while others identified that transactivation of the PPARc
signaling pathway by fatty acids is essential for rat liver
regeneration [11]. Moreover, liver-specific PPARc-null mice with
diet-induced hepatic steatosis have reduced hepatic regeneration
after PH [10]. Thus, a clear reappraisal for the role of PPARa and
PPARc in liver regeneration might be necessary.
Unlike PPARa and PPARc, the role of PPARb in liver
regeneration has not been studied. In addition to regulating
glucose and lipid metabolism, PPARb displays an anti-inflamma-
tory activity, which could be important in the modulation of liver
regeneration [14]. Ligand activation of PPARb protects against
CCl4-induced hepatotoxicity by repression of pro-inflammatory
genes [15]. Compared with its anti-inflammatory role, the function
of PPARb in regulating cell fate is more complicated. GW501516-
activated PPARb promotes liver repair by stimulating hepatic
stellate cell proliferation via the p38 and JNK MAPK pathways in
CCl4 treated mice [16]. Regarding dermatological wound healing,
PLOS ONE | www.plosone.org 1 June 2013 | Volume 8 | Issue 6 | e65644
PPARb increases mouse keratinocyte survival via activation of
PDK1/Akt signaling or ceramide kinase after injury [17,18].
However, ligand activation of PPARb inhibits cell proliferation in
human HaCat keratinocytes [19]. In tumor cell lines, PPARb
activation promotes the proliferation of human breast and prostate
cancer cell, but had no effect on the proliferation of A549 and
H1838 human lung cancer cells [20,21]. Hence, the proliferative
effect of PPARb seems to be cell type-specific and the role of
PPARb in liver regeneration remains to be determined.
The current study tests the hypothesis that PPARb has a role in
regulating liver regeneration. The data showed that liver
regeneration was delayed in PPARb-null (KO) mice. Differential
gene expression profiling revealed the inhibition of expression in
genes and pathways that are involved in metabolism and
proliferation in regenerating KO livers. Specifically, PPARb
deficiency affected the activation of Akt and the expression of
E2fs. Pathways that control glycolysis, FA synthesis as well as cell
proliferation were de-regulated in regenerating PPARb KO livers.
The data suggest a role for PPARb in regulating liver regeneration
that is mediated at least in part through Akt and E2f-regulated
pathways.
Materials and Methods
Mice, Partial Hepatectomy, and Sample Preparation
Wild-type (WT) and PPARb-null mice (KO) male mice (3–5
month, C57BL/6) were kept in steel microisolator cages at 22uC
with a 14-hr/10-hr light/dark cycle. Food and water were
provided ad libitum throughout the entire feeding period. Standard
PH was performed using the procedure described previously [1].
Mice were killed at the indicated time-points. The liver and body
weights at the time of death were used to calculate the liver-to-
body-weight ratios. The results obtained were the mean of three to
five mice per time point. Part of the livers were fixed in 10%
formalin, embedded in paraffin, and stained for histological
analysis. All the animal experiments were conducted in accor-
dance with the National Institutes of Health Guide for the Care
and Use of Laboratory Animals under protocols approved by the
University of California Davis Animal Care and Use Committee.
Ki-67 Immunostaining
Immunostaining was performed with primary Ki-67 antibody
(NeoMarkers, Fremont, CA) to monitor hepatocyte proliferation.
The number of Ki-67-labeled nuclei was counted in at least 10
low-magnification (20X) microscope fields for each section.
Western Blot
Liver protein (40 mg) was electrophoresed on SDS-polyacryl-
amide gels under reducing conditions. Proteins from the gels were
transferred to the polyvinylidene fluoride membrane. Antibodies
specific for PDK1, Akt, p-Akt (Thr308), Cyclin D, Cyclin E (Cell
Signaling Technology, Danvers, MA), and b-Actin (Santa Cruz
Biotechnology, Santa Cruz, CA) were used for detection of
proteins.
RNA-sequencing Library Construction, Sequencing, and
Bioinformatics Analysis
Mouse liver RNA was prepared using TRIzol (Invitrogen,
Carlsbad, CA). RNA concentration and integrity were determined
by the Agilent 2100 Bioanalyzer using a RNA Nano Bioanalysis
Chip. RNA-sequencing library preparation and sequencing was
carried out by the Genome Sequencing Facility at University of
Kansas Medical Center (Kansas City, KS). cDNA libraries were
prepared with 2 mg of total RNA using the TruSeq RNA Sample
Preparation Kit (Illumina). The libraries were clustered and
sequenced on an Illumina HiSeq 2000 instrument with 100 bp
single end reads.
Total reads of RNA-sequencing experiments were analyzed
using the combination of TopHat (2.0.0) and Cufflinks (1.3.0) [22].
TopHat was used to align reads to the mouse reference genome
(NCBI37, mm9) and discover transcript splice sites. These
alignments from TopHat were then assembled into transcripts
using Cufflinks. Cuffdiff, a component of the Cufflinks package,
was used to estimate FPKM (fragments per kilobase of exon model
per million mapped fragments) and differentially express tran-
scripts. Statistics on the libraries and the number of tags mapped
are presented in Table 1. The differential expression analysis was
done by using the Baggerley’s test. The genes that have differential
expression levels were extracted with a Benjamini-Hochberg
corrected p-value,0.005 for pathway analysis. The RNA-seq data
discussed in this paper have been deposited in NCBI Gene
Expression Omnibus and are accessible through Series accession
number GSE47062 (http://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?acc = GSE47062). All biological function and pathway
analyses were performed using the Functional Annotation Tool in
the Database for Annotation, Visualization and Integrated
Discovery (DAVID, david.niaid.nih.gov). Functional pathways
or processes with p,0.05 and Bonferroni value ,0.1 were
accepted.
Real-time Quantitative Polymerase Chain Reaction (qPCR)
Hepatic RNA isolated by TRIzol (Invitrogen, Carlsbad, CA)
was reverse transcribed to generate cDNA followed by amplifica-
tion using the ABI Prism 7900HT sequence detection system
(Applied Biosystems, Foster City, CA). The hepatic mRNA levels
were normalized to GAPDH mRNA level.
Statistical Analysis
Data are given as mean 6 SD. Statistical analysis was
performed using Student’s t test or one-way analysis of variance.
Significance was defined by p,0.05.
Results
Growth Suppression after PH in PPARb-null Mice
PH was done in WT and KO mice, and livers were collected 1–
3 days after the surgery. Liver-to-body weight ratios were
significantly reduced in regenerating KO livers in comparison
with the regenerating WT livers at 36–48 hr (Fig. 1A). Ki-67
immunohistochemistry showed that the number of proliferating
hepatocytes rapidly increased and peaked at 36–48 hr after PH in
WT livers (Fig. 1B). In contrast, the number of Ki-67-positive
hepatocytes in KO livers was significantly less than that in WT
livers at 36–48 hr (Fig. 1C). However, the significantly higher
number of Ki-67-positive hepatocytes in KO livers than that in
WT livers indicated the compensatory proliferation in KO livers
after delayed regeneration. Since Ki-67 protein is present during
all active phases of the cell cycle (G1, S, G2, and mitosis), but is
absent from resting cells (G0), the data indicated that there was
about one day delay in cell proliferation due to lack of PPARb.
Differential Gene Expression Profiling after PH
RNA-sequencing was performed using hepatic RNA derived
from WT and KO mice 48 hr after PH to study the mechanism
underlying delayed cell proliferation due to PPARb deficiency.
The data showed that 88% of the reads were mapped to mm9.
Figure 2A showed that 1344 genes (1126 down- and 218 up-
regulated) had more than a 2-fold change at the mRNA level due
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to PPARb deficiency. Biological function analysis of these genes
showed that a majority (68%) are involved in cell cycle control,
DNA replication, and lipid homeostasis. Moreover, 437 out of
1344 genes could be assigned to 34 KEGG pathways that include
21 metabolism and 13 cell proliferation pathways (Fig. 2B).
Suppression of PDK1/Akt and Abolishment of E2f
Activation by PPARb Deficiency
Since PDK1/Akt is downstream to PPARb [23], we determined
the expression of PDK1/Akt in regenerating WT and KO livers
by western blotting. The results showed that the PDK1/Akt
pathway was activated 36–48 hr after PH in WT livers and such
activation was absent in KO livers (Fig. 3A). It was shown that Akt
can regulate E2f activity [24], so the expression of E2fs was studied
by qPCR. The data showed that expression levels of E2f1-2, and
E2f7-8 peaked at 36–48 hr when hepatocytes are actively
proliferating in WT mice (Fig. 4B–E). However, the cell
proliferation-associated induction of E2f1-2, and E2f7-8 mRNA
was either reduced or not found in regenerating KO livers.
Transcript isoforms analysis was performed for the E2fs. Changes
in E2f1-2 and E2f7-8 expressions were mainly due to the increased
expression levels of isoforms ENSMUST00000103145 (E2f1),
ENSMUST00000061721 (E2f2), ENSMUST00000073781 (E2f7),
and ENSMUST00000058745 (E2f8) 48 hr in WT mice (Fig. 3F).
The levels of E2f3-4 and E2f5-6 mRNAs did not change in both
WT and KO regenerating livers (data not shown). Consistently,
qPCR data showed that the expressions of 38 E2fs target genes
involved in cell cycle control, DNA repair and replication, as well
as G2/M checkpoints were suppressed due to PPARb deficiency
(48 hr after PH) (Fig. 4A). We further studied the expression of
some of the differentially expressed E2fs targets during liver
regeneration in both WT and KO mice. The expression of a few
genes involved in cell cycle control was also studied due to their
importance for proliferation. The data showed that the expression
of Cyclin D was higher in WT than KO at 24–36 hr (Fig. 4B). In
addition, western blots indicated that Cyclin D level was induced
at 36–48 hr in WT mice and the increase was absent in
regenerating KO mice (Fig. 4C). Similarly, quantification of
hepatic Cyclin E/Cdk2 and Cyclin A, B/Cdk1 mRNAs revealed
that they were increased in regenerating WT, but not in KO livers
(36–48 hr) (Fig. D-H). The level of Cyclin E protein was increased
at 36–48 hr in WT, but not in KO, mouse livers (Fig. 4I).
Inhibition the Expression of Genes Involved in Glycolysis
in Regenerating PPARb-null Livers
Nineteen genes involved in the glycolysis pathway showed
differential expression in regenerating WT and KO livers (.1.5
fold). All the shaded genes shown in figure 5A had elevated
expression levels in regenerating WT, but not in KO, mouse livers
(48 hr). The findings were confirmed by qPCR. The expression of
genes involved in glycolysis (Hexokinase 2, Hk2; Glucose
phosphate isomerase 1, Gpi1; Phosphofructokinase, Pfkl; Aldolase
C, Aldoc; Glyceraldehyde-3-phosphate dehydrogenase, Gapdhs;
Phosphoglycerate kinase 1, Pgk1; Phosphoglucomutase 1, Pgm1;
Enolase 1, Eno1; Pyruvate kinase liver and red blood cell, Pklr)
were analyzed at time-points during liver regeneration. All except
Hk2 at 24 hr, showed higher expression levels in WT than KO at
24, 36, and 48 hr after PH (Fig. 5B–J). Four genes, Pfkl, Aldoc,
Gapdhs, and Pgm1, showed higher expression levels in KO than
WT at 60 or 72 hr after PH thus suggesting a compensatory effect
at a later time.
Inhibition the Expression of Genes Associated with
Cholesterol, Triglyceride, and Fatty Acid Biosynthesis in
Regenerating PPARb-null Livers
Ninety-seven genes that regulate lipid homeostasis showed
differential expression in regenerating WT and KO mouse livers.
Among them, 14 and 12 genes are involved in cholesterol
metabolism and FA synthesis, respectively (Fig. 6A–B). qPCR has
confirmed that all of them had higher expression levels in WT
mice. The expression of four genes (Sterol regulatory element-
binding protein, Srebp; ATP citrate lyase, Acly; FA synthase, Fasn;
Acetyl-Coenzyme A carboxylase alpha, Acc) were also examined
at all time-points during liver regeneration. The induction of
Srebp peaked at 24 hr and was sustained until 48 hr in WT mice.
However, the induction of Srebp in KO did not occur until 60 hr
after PH (Fig. 6C). Consistent with the expression profile of Srebp
in WT and KO mice, all the studied downstream targets of Srebp
(Acly, Fasn, and Acc) showed higher expression in WT than KO
36–48 hr after PH. (Fig. 6D–F).
Morphological data showed that WT mice accumulated lipid
droplets in hepatocytes 36 hr after PH (Fig. 7A) whereas this
transient steatosis was not noted in KO mice at the same time-
point. There were no signs of steatosis in sham-operated WT and
KO mice. Moreover, the expression levels of PPARa and PPARc
were also higher in WT than KO mice 36 hr after PH (Fig. 7B–C).
Table 1. Summary statistics of Illumina 100 paired-end runs.
Classification Number of transcripts
Wild type PPARb-null
Potential novel isoform 7186 6914
Full match 10591 10090
Intronic 2785 2894
Possible polymerase run 1862 1818
Unknown 515 452
Generic reference exon overlap with a reference transcript 2257 2282
Exonic overlap with reference on opposite strand 540 563
Intron overlap 0 1
Single exon with partial intron overlap 994 1035
Total assembled transcripts 26970 26222
doi:10.1371/journal.pone.0065644.t001
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Discussion
The role of PPARb in regulating lipid and carbohydrate
homeostasis as well as proliferation has been shown in adipose
tissue, muscle, skin, lung, colon using in vivo and in vitro models
[25]. However, the results are inconsistent across the different
models. For example, synthetic PPARb agonists promote choles-
terol accumulation in human macrophages [26]. However, fat
mass is not reduced in adipose-specific PPARb-null mice [27]. In
terms of cell proliferation, human keratinocytes treated with
PPARb ligands (L165041 or GW501516) had increased cell
proliferation [28], while decreased cell proliferation was found in
human HaCaT keratinocytes treated with GW501516 [29].
Controversial findings also exist in with PPARb function in
various cancer cells. For instance, PPARb activation has been
shown to stimulate proliferation of breast cancer cells (MCF-7,
T47D, LNCaP), but not human colon carcinoma cells (HT29,
HCA-7, SW480) [20]. Despite efforts to study PPARb in different
tissues, the role of PPARb in regulating hepatocyte proliferation
has never been studied. Using the PH-induced liver regeneration
model, we report for the first time that PPARb is involved in liver
regeneration. Gene profiling after PH of WT and KO mice
provided insight into the cellular mechanisms relevant to the role
of PPARb in liver regeneration. Our data showed that PPARb has
Figure 1. Delayed liver regeneration in PPARb-null (KO) mice. (A) Liver-to-body weight ratios in wild-type (WT) and KO mice after PH. (B)
Representative photomicrographs of Ki-67 immunohistochemical staining of liver sections from WT and KO mice at 24, 36, 48, 60, and 72 hours after
PH (n = 3). (C) Ki-67 positive cells in the livers of WT and KO mice over a time course after PH. The number of proliferating hepatocytes was
determined by counting the Ki-67 positive hepatocytes in at least 15 low-magnification (20 X) microscope fields for each sample. Liver sections from
all mice were used for analyses. Means 6 SD are graphed. * p,0.05.
doi:10.1371/journal.pone.0065644.g001
PPARb Regulates Liver Regeneration
PLOS ONE | www.plosone.org 4 June 2013 | Volume 8 | Issue 6 | e65644
PPARb Regulates Liver Regeneration
PLOS ONE | www.plosone.org 5 June 2013 | Volume 8 | Issue 6 | e65644
Figure 2. Visualization of RNA-sequencing for differential expressed genes in regenerating wild type (WT) and PPARb-null (KO)
mouse livers. (A) Volcano plots showing the magnitude of gene expression ratios (log2) (x-axis) as a function of difference between WT and KO, are
displayed on the y-axis [-log10 (p value)]. Horizontal dotted line corresponds to a p value cutoff of 0.01. Vertical dotted line delimits up- and down-
regulation of KO/WT. (B) Pathway analysis of the 1344 differentially expressed genes with significance by DAVID. The 1344 transcriptomes
significantly differentially expressed were extracted with a Benjamini-Hochberg corrected p value,0.005 for pathway analysis. 437 out of 1344 genes
could be assigned to 34 KEGG pathways that include 21 metabolism and 12 cell proliferation pathways. The number of genes involved in each
pathway is indicated.
doi:10.1371/journal.pone.0065644.g002
Figure 3. Western blot for PDK1/Akt pathway and gene expression of E2fs. (A) Protein levels of the PDK1/Akt pathway in wild-type (WT)
and PPARb-null (KO) mice. Hepatic gene expression levels of (B) E2f1, (C) E2f2, (D) E2f7, and (E) E2f8 over a time course from 0 to 72 hours after PH by
qPCR (n = 3). (F) Differential analysis results for E2fs. Expression plot shows clear differences in the expression of E2f1, 2, 7, 8 between KO versus WT
mice, measured in fragments per kilobase of exon per million fragments mapped (FPKM). Expression of a transcript is proportional to the number of
reads sequenced from that transcript after normalizing for that transcript’s length. Means 6 SD are graphed. * p,0.05.
doi:10.1371/journal.pone.0065644.g003
PPARb Regulates Liver Regeneration
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a role in liver regeneration by regulating metabolism and cell
proliferation. It is clear that proliferation requires an adapted
metabolic response of the cells; hence, PPARb-mediated metab-
olism is likely linked to cell proliferation.
Akt, which is a downstream target of PPARb [24], has a dual
and integrated role in regulating metabolism and proliferation. In
terms of metabolism, Akt regulates glucose homeostasis as well as
FA synthesis [30]. Activation of Akt in 4-hydroxytamoxifen-
treated human retinoic pigment epithelial cells induces the
expression of genes that are involved in cholesterol and FA
biosynthesis [31]. In addition, Akt can activate Srebp to up-
regulate the expression of Fasn and Acc, which are the key
enzymes involved in FA synthesis [32]. Our data showed the
activation of PDK1/Akt, which was accompanied by up-
regulation of Srebp, Acly, Fasn, and Acc 24–36 hrs after PH in
WT mice. However, such coordinated up-regulation was not
found in regenerating PPARb-null mice. Of particular importance
is that Acly is a key enzyme integrating glucose and lipid
metabolism pathways [33]. For proliferation to occur, glycolytic
flux needs to be induced to convert glucose into pyruvate, which
leads to the production of lactate and acetyl-CoA to facilitate FA
synthesis [34]. The up-regulation of Acly in regenerating liver can
result in increased acetyl-CoA production, leading to enhanced
cholesterogenesis and lipogenesis [35], which may cause fat
accumulation found in regenerating liver to stimulate cell
proliferation. In contrast, the lack of induction of Acly in
regenerating PPARb livers failed to induce glycolysis and FA
synthesis that resulted in no fat accumulation and delayed
hepatocyte proliferation in PPARb mice.
E2fs regulate the expression of both proliferative and metabolic
genes [35]. They are essential to regulate genes that are involved
in DNA replication and cell cycle progression by exerting cell-
cycle-specific expression pattern and by binding directly to the
E2f-binding sites [2]. The classical E2fs, which include E2f1-6,
regulate the transcription of target genes when bound to the
promoters as heterodimers with a ‘‘differentiation regulated
transcription factor protein’’ (DP) while the atypical E2f7-8 bind
to promoters as homodimers or heterodimers without a DP. The
E2f family is split into two groups by function: transcription
activators and repressors. Activators such as E2f1-3 promote cell
cycle progression, while repressors (E2f4-8) inhibit cell cycle [36].
E2f7-8 can inhibit the action of E2f1 via a negative feedback loop
[35]. Since some E2f family members may have overlapping
functions, loss of one family member may be compensated by
Figure 4. Depressed E2f downstream target gene expression in PPARb-null (KO) mice after PH. (A) qPCR analysis of E2f target gene
involved in cell cycle, DNA synthesis and replication, and DNA repair. (B) Real time qPCR analysis of Cyclin D over a time course from 0 to 72 hours
after PH. (C) Western blot analysis of Cyclin D at 36–48 hr after PH. Real time qPCR analysis of (D-E) Cyclin E/Cdk2, and (G-H) Cyclin A, B/Cdk1 in wild-
type (WT) and KO mice over a time course from 0 to 72 hours after PH. (I) Western blot analysis of Cyclin E at 36–48 hr after PH (n = 3). Means 6 SD
are graphed. * p,0.05.
doi:10.1371/journal.pone.0065644.g004
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Figure 5. Gene expression of key metabolic enzymes involved in glycolysis in wild-type (WT) and PPARb-null (KO) mice after PH. (A)
Glucose metabolism pathway. Major metabolic enzymes and intermediates are shown. Genes identified by RNA-sequencing and confirmed by
quantitative real-time PCR are shaded; the number after each gene name means the ratio of gene expression of WT/KO. Biological pathway analysis
was performed by using GenMAPP Pathway (http://www.genmapp.org). Hepatic gene expression levels of (B) Hk2, (C) Gpi1, (D) Pfkl, (E) Adloc, (F)
Gapdhs, (G) Pgk1, (H) Pgm1, (I) Eno1, and (J) Pklr in WT and KO mice over a time course from 0 to 72 hours after PH (n = 3). Means6 SD are graphed. *
p,0.05.
doi:10.1371/journal.pone.0065644.g005
Figure 6. Pathways for major lipid metabolism. (A) cholesterol biosynthesis. (B) triglyceride biosynthesis and fatty acid synthesis. Major
metabolic enzymes and intermediates are shown. Genes identified by RNA-sequencing and confirmed by quantitative real-time PCR are shaded; the
number after each gene name means the ratio of gene expression of wild-type (WT)/PPARb-null (KO). Biological pathway analysis was performed by
using GenMAPP Pathway (http://www.genmapp.org). Hepatic gene expression levels of (C) Srebp, (D) Acly, (E) Fasn, and (F) Acc, in WT and KO mice
over a time course from 0 to 72 hours after PH (n = 3). Means 6 SD are graphed. * p,0.05.
doi:10.1371/journal.pone.0065644.g006
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another [35]. This may explain why E2f1 deficiency has no effect
on liver regeneration [37]. Our data showed that among the eight
E2fs studied, four (E2f1-2 and E2f7-8) increased their expression
levels during liver regeneration. The induction E2f1 mRNA level
was up more than 25 fold at 36 hr after PH. However, such
inductions were either not noted or drastically reduced in KO
mice. Moreover, thirty-eight downstream genes of E2fs involved in
cell cycle regulation, DNA replication and repair, as well as
checkpoint control, failed to be up-regulated in regenerating KO
livers. These findings not only implied that PPARb has a role in
coordinating the regulation of multiple E2fs, but also suggested
that PPARb-mediated E2f actions might be essential for the
normal progression of liver regeneration.
E2f1 is the best characterized member of the E2f family
members. E2f1 orchestrates a complex control of oxidative and
glycolytic metabolisms that are essential for cell proliferation and
adaptation to energy demands [35]. Activation of E2f1 increases
glucose-stimulated insulin secretion and favors the process of
glycolysis in pancreatic b-Min6 cells [38]. Decreased insulin
secretion was identified in E2f1-null mice [38]. Our data showed
that about 70% of the genes involved in glycolysis and FA
synthesis pathways failed to be induced during liver regeneration
due to PPARb deficiency (48 hr after PH). These findings
suggested that the role of PPARb in regulating liver metabolism
and cell proliferation during liver regeneration might be through
E2fs.
Figure 7. Lipid accumulation in wild-type (WT) and PPARb-null (KO) mice after PH. (A) Hematoxylin and eosin staining shows lipid
accumulation in WT mice, but not in KO mice, 36 hr after PH. Sham tissue used as negative control. (B) Hepatic gene expression levels of (B) PPARa
and (C) PPARc in WT and KO mice over a time course from 0 to 72 hours after PH (n = 3). Means 6 SD are graphed. * p,0.05.
doi:10.1371/journal.pone.0065644.g007
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Because of the significant role of E2fs in cell cycle and
metabolism, it is important to understand the mechanism by
which E2fs are regulated. Since Akt, the downstream of PPARb,
activates E2f in NIH3T3 fibroblast cells and Akt phosphorylation
correlates with increased E2F mRNA level [24,39], the regulation
of E2f by PPARb might be Akt dependent. Furthermore, at the
transcriptional level, by performing motif analysis of our published
ChIP-sequencing data, we found that hepatic retinoid6receptor a
(RXRa) bound to E2f1 and E2f2 (Chr2:154388649–154388661,
Chr4:135737726–135737738, respectively) in mouse liver [40]. It
was shown that the PPARc agonist rosiglitazone increases the
binding of PPARc to DR1 sites in the E2f1 and E2f2 gene
promoters in 3T3-L1 cells [41]. The RXRa binding site found in
mouse liver coincides with the RXRa/PPARc binding sites found
in 3T3-L1 cells. E2fs regulate adipocyte differentiation through
modulating the expression of PPARc in 3T3-L1 preadipocytes
[39]. Moreover, the binding of RXRa to the E2f1 and E2f2 in
mouse livers could also be enriched by treating mice with all-trans
retinoic acid (unpublished). These data indicate that E2f1-2 can be
transcriptionally regulated by RXRa/PPARc. Whether E2f1-2
can be directly regulated by PPARb remains to be determined. It
is worth noting that the basal level of E2f1-2 is not different
between the WT and KO mice, the differential expressions of E2fs
are only found when hepatocytes are actively proliferating, thus
reflecting the cell cycle-specific expression pattern of E2fs. It is
interesting to note that there is substantially hepatic lipid
accumulation 36 hr after PH. The role of the accumulated lipid
may function as an energy source for liver regeneration [42]. It is
possible that the accumulated lipid in regenerating liver serves as a
ligand for PPARc or b, which in turn activates E2f1-2 and lead to
metabolism and cell proliferation. Thus, the transcriptional
induction of E2fs could be due to activation of Akt or the FA-
activated PPARc pathway. This scenario is further supported by
our findings that PPARc is induced in regenerating WT mouse
livers.
Taken together, our data showed the potential interaction
between PPARb and E2fs in regulating metabolism and cell
proliferation in regenerating mouse liver. The lack of activation of
PDK1/Akt and E2fs-mediated pathways due to PPARb deficiency
resulted in delayed regeneration (Fig. 8). It would be interesting to
test whether activation of PPARb can facilitate liver regeneration
and this work is currently on going.
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Figure 8. Summary for the role of PPARb in regulating liver regeneration through E2f-regulated pathway. PPARb up-regulates Akt- and
E2fs, which control glycolysis, fatty acid homeostasis as well as cell proliferation in regenerating livers. In terms of metabolism, E2fs gene regulation
facilitates glucose-stimulated insulin secretion and the breakdown of glucose through glycolysis. E2fs regulate lipid homeostasis through modulating
PPARc expression. Akt activates the key enzymes involved in fatty acid synthesis. Moreover, Acly enhances cholesterogenesis and lipogenesis that
may lead to fat accumulation in regenerating liver where it is used to stimulate cell proliferation. The produced fatty acid activates PPARc, which
might regulate E2fs through a feedback loop. Consequently, these metabolic activities generate energy and intermediates for cell proliferation. In
addition to their roles in cell metabolism, Akt also regulates cell cycle through Cyclin D/Cdk4 complex while E2fs modulate cell cycle regulation, DNA
replication and repair, as well as checkpoint control.
doi:10.1371/journal.pone.0065644.g008
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